BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 29348263)

  • 1. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
    Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
    Zheng D; Zhang Y; Zheng M; Cao T; Wang G; Zhang L; Ni R; Brockman J; Zhong H; Fan GC; Peng T
    Clin Sci (Lond); 2019 Jul; 133(13):1505-1521. PubMed ID: 31266854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38δ genetic ablation protects female mice from anthracycline cardiotoxicity.
    George SA; Kiss A; Obaid SN; Venegas A; Talapatra T; Wei C; Efimova T; Efimov IR
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H775-H786. PubMed ID: 32822209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT
    Huang CY; Chen JY; Kuo CH; Pai PY; Ho TJ; Chen TS; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jan; 233(1):463-475. PubMed ID: 28295305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of autophagy in doxorubicin-induced cardiotoxicity.
    Dirks-Naylor AJ
    Life Sci; 2013 Dec; 93(24):913-6. PubMed ID: 24404586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary cyanidin 3-glucoside from purple corn ameliorates doxorubicin-induced cardiotoxicity in mice.
    Petroni K; Trinei M; Fornari M; Calvenzani V; Marinelli A; Micheli LA; Pilu R; Matros A; Mock HP; Tonelli C; Giorgio M
    Nutr Metab Cardiovasc Dis; 2017 May; 27(5):462-469. PubMed ID: 28428026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
    Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway.
    Maulik A; Davidson SM; Piotrowska I; Walker M; Yellon DM
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):245-253. PubMed ID: 29766336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism.
    Carnevale D; Vecchione C; Mascio G; Esposito G; Cifelli G; Martinello K; Landolfi A; Selvetella G; Grieco P; Damato A; Franco E; Haase H; Maffei A; Ciraolo E; Fucile S; Frati G; Mazzoni O; Hirsch E; Lembo G
    Cardiovasc Res; 2012 Jan; 93(1):200-9. PubMed ID: 22038741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
    Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
    Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity.
    Durrant DE; Das A; Dyer S; Tavallai S; Dent P; Kukreja RC
    Mol Pharmacol; 2015 Sep; 88(3):512-23. PubMed ID: 26101222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-induced cardiotoxicity involves IFNγ-mediated metabolic reprogramming in cardiomyocytes.
    Ni C; Ma P; Wang R; Lou X; Liu X; Qin Y; Xue R; Blasig I; Erben U; Qin Z
    J Pathol; 2019 Mar; 247(3):320-332. PubMed ID: 30426505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
    Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
    Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.